Medicare Enrolled

Dr. Kenneth Lomenzo, M.D.

Family Medicine · Groesbeck, TX
701 MCCLINTIC DR, Groesbeck, TX 76642
2547293411
Registered in NPPES since 2006
NPI: 1861442642 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lomenzo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lomenzo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lomenzo

Dr. Kenneth Lomenzo is a family medicine specialist in Groesbeck, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Lomenzo received a total of $6,033 from 36 pharmaceutical and/or device companies across 381 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lomenzo is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $6,033 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,033
Total received (2018-2024)
Avg $862/year across 7 years
Top 10% in TX for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
381
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,153
2023
$1,046
2022
$956
2021
$1,112
2020
$728
2019
$714
2018
$323

Payments by company (2024)

Phathom Pharmaceuticals, Inc.
$278
ABBVIE INC.
$186
Novo Nordisk Inc
$149
Otsuka America Pharmaceutical, Inc.
$110
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$89
Amgen Inc.
$83
AstraZeneca Pharmaceuticals LP
$49
PFIZER INC.
$43
GlaxoSmithKline, LLC.
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
Lilly USA, LLC
$30
Dexcom, Inc.
$20
Abbott Laboratories
$14
Merck Sharp & Dohme LLC
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Top 3 companies account for 53.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$787
ABBVIE INC.
$758
Amgen Inc.
$572
AstraZeneca Pharmaceuticals LP
$571
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$308
Otsuka America Pharmaceutical, Inc.
$284
Phathom Pharmaceuticals, Inc.
$278
Mylan Specialty L.P.
$249
SANOFI-AVENTIS U.S. LLC
$245
Bayer HealthCare Pharmaceuticals Inc.
$229
GlaxoSmithKline, LLC.
$227
Astellas Pharma US Inc
$182
PFIZER INC.
$147
Allergan, Inc.
$137
Boehringer Ingelheim Pharmaceuticals, Inc.
$116
ITI, Inc.
$115
Takeda Pharmaceuticals U.S.A., Inc.
$108
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$89
AbbVie Inc.
$88
Lilly USA, LLC
$61
Dexcom, Inc.
$60
Merck Sharp & Dohme LLC
$60
Merck Sharp & Dohme Corporation
$54
Allergan Inc.
$40
Amarin Pharma Inc.
$30
Radius Health, Inc.
$30
Sunovion Pharmaceuticals Inc.
$29
Biogen, Inc.
$28
Supernus Pharmaceuticals, Inc.
$25
Esperion Therapeutics, Inc.
$24
Corium, LLC
$24
Biohaven Pharmaceutical Holding Company Ltd.
$18
Eisai Inc.
$17
Biohaven Pharmaceuticals, Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Abbott Laboratories
$14
Top 3 companies account for 35.1% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · AZSTARYS · Aimovig · Amitiza · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CAPLYTA · CHANTIX · Dayvigo · Dexcom G6 Transmitter · Dymista · EMGALITY · EVENITY · FARXIGA · GARDASIL · GEMTESA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LONHALA MAGNAIR · LYRICA · M-M-R II · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · OFEV · Otezla · Ozempic · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · QELBREE · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · STEGLATRO · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TZIELD · Tresiba · Trintellix · Tymlos · UBRELVY · VAXNEUVANCE · VOQUEZNA · VRAYLAR · Vascepa · Wegovy · XIFAXAN · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a family medicine specialist in Groesbeck?
Compare family medicine physicians in the Groesbeck area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians in nearby ZIP areas
15
County median income
$58,109
Nearest hospital to ZIP centroid (approximate)
LIMESTONE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lomenzo is a family medicine specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Lomenzo receive payments from pharmaceutical companies?
Yes. Dr. Lomenzo received a total of $6,033 from 36 companies across 381 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Lomenzo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →